Skip to Content
Merck
  • Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.

Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.

Journal of pharmaceutical sciences (2014-09-12)
Kayo Yuminoki, Fuko Seko, Shota Horii, Haruka Takeuchi, Katsuya Teramoto, Yuichiro Nakada, Naofumi Hashimoto
ABSTRACT

In this study, we reported the application of Povacoat®, a hydrophilic polyvinylalcohol copolymer, as a dispersion stabilizer of nanoparticles of poorly water-soluble compounds. In addition, the influence of aggregation of the nanoparticles on their solubility and oral absorption was studied. Griseofulvin (GF) was used as a model compound with poor water solubility and was milled to nanoparticles by wet bead milling. The dispersion stability of GF milled with Povacoat® or the generally used polymers (polyvinylalcohol, hydroxypropylcellulose SSL, and polyvinylpyrrolidone K30) was compared. Milled GF suspended in Povacoat® aqueous solution with D-mannitol, added to improve the disintegration rate of freeze-dried GF, exhibited high dispersion stability without aggregation (D90 = ca. 0.220 μm), whereas milled GF suspended in aqueous solutions of the other polymers aggregated (D90 > 5 μm). Milled GF with Povacoat® showed improved aqueous solubility and bioavailability compared with the other polymers. The aggregation of nanoparticles had significant impact on the solubility and bioavailability of GF. Povacoat® also prevented the aggregation of the various milled poorly water-soluble compounds (hydrochlorothiazide and tolbutamide, etc.) more effectively than the other polymers. These results showed that Povacoat® could have wide applicability to the development of nanoformulations of poorly water-soluble compounds.

MATERIALS
Product Number
Brand
Product Description

Aciclovir, European Pharmacopoeia (EP) Reference Standard
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Mannitol, European Pharmacopoeia (EP) Reference Standard
Indomethacin, European Pharmacopoeia (EP) Reference Standard
Supelco
Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
D-Mannitol, ≥99.9999% (metals basis), for boron determination
Sigma-Aldrich
D-Mannitol, tested according to Ph. Eur.
Sigma-Aldrich
D-Mannitol, BioUltra, ≥99.0% (sum of enantiomers, HPLC)
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
Griseofulvin, from Penicillium griseofulvum, 97.0-102.0%
Sigma-Aldrich
D-Mannitol, meets EP, FCC, USP testing specifications
Sigma-Aldrich
D-Mannitol, ≥98% (GC), suitable for plant cell culture
Sigma-Aldrich
D-Mannitol, ≥98% (GC)
Sigma-Aldrich
D-Mannitol, BioXtra, ≥98% (HPLC)
Sigma-Aldrich
Acycloguanosine, ≥99% (HPLC), powder
Supelco
Griseofulvin, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Mannitol, United States Pharmacopeia (USP) Reference Standard
USP
Griseofulvin, United States Pharmacopeia (USP) Reference Standard
Supelco
Mannitol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-Mannitol, ACS reagent
USP
Acyclovir, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Millipore
D-Mannitol, ACS reagent, ≥99.0%, suitable for microbiology
Supelco
Hydrochlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material
Piroxicam, European Pharmacopoeia (EP) Reference Standard
Piroxicam for system suitability, European Pharmacopoeia (EP) Reference Standard
Phenytoin, European Pharmacopoeia (EP) Reference Standard
Phenytoin for system suitability, European Pharmacopoeia (EP) Reference Standard
USP
Piroxicam, United States Pharmacopeia (USP) Reference Standard